✦ LIBER ✦

1099 A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced renal cell carcinoma (RCC)

✍ Scribed by Connolly, N.; Shaw, D.; Patel, P.; Garner, C.; Beirne, D.; Kilany, S.; Hedlund, G.; Forsberg, G.; Stern, P.; Hawkins, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of a 5T4 oncofoetal ant

✍ Shaw, D M; Connolly, N B; Patel, P M; Kilany, S; Hedlund, G; Nordle, Ö; Forsberg 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 329 KB

O-151 Phase II study of anatumomab mafen

✍ Langer, Corey J.; Katherine Alpaugh, R.; Robert, Francisco; Weiner, L.M.; Schill 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

49LBA Final results of a Phase II random

✍ P. Mulders; R. Hawkins; P. Nathan; I. de Jong; S. Osanto; E. Porfiri; A. Prother 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

PHASE I/II STUDY OF THE TUMOUR-TARGETING

✍ M. Johannsen; A. Roemer; J. Roigas; G. Curigliano; G. Spitaleri; L. Giovannoni; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Randomized phase II study of multiple do

✍ Donald L. Trump 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 35 KB